10 results · 18ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

i-STAT hs-TnI cartridge with the i-STAT Alinity System

FDA 510(k)
FDA Class 2 ·Clinical Chemistry

ceraMotion®

FDA UDI
DENTAURUM GmbH & Co.KG·J011253051200·ceraMotion® Lf Dentin C2, 20 g / dental ceramic...

VANGUARD REPROCESSED EXTERNAL FIXATION DEVICES

FDA 510(k)
FDA Class 2 ·Orthopedic

Nitrile Patient Examination Gloves (Tested for Use with Chemotherapy Drugs)

FDA 510(k)
FDA Class 1 ·General Hospital

CANN CONNECTING SCR F/PERCUTAN INSTRUMENTS FOR NAILS-EX

FDA Adverse Event
Malfunction ·WRIGHTS LANE SYNTHES USA PRODUCTS LLC·Product code FZX·January 26, 2018

ARTICULEZE M HEAD 36MM -2

FDA Adverse Event
Injury ·DEPUY ORTHOPAEDICS, INC.·Product code JDI·December 4, 2008

ACCU-CHEK SPIRIT

FDA Adverse Event
Malfunction ·ROCHE INSULIN DELIVERY SYSTEMS INC.·Product code LZG·August 31, 2011

PARADIGM REAL-TIME INSULIN INFUSION PUMP

FDA Adverse Event
Malfunction ·MEDTRONIC MINIMED·Product code OYC·July 29, 2013

EQUINOXE COMPRESSION SCREW

FDA Adverse Event
Injury ·EXACTECH, INC.·Product code KWT·September 12, 2024

Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014